Lexpos News

PSNC Chief Executive Janet Morrison has recorded a video update for community pharmacy contractors following PSNC’s November Committee meeting. Janet opens the video by emphasising that both PSNC staff and Committee Members know how difficult things are at the moment, and says that she wants to give some honest feedback on where the sector is [...]

The post Protecting Pharmacy Funding: A video update from PSNC’s CEO appeared first on PSNC Website.

Following applications made by PSNC to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), a further 5 new products will be classed as ‘Drugs for which Discount is Not Deducted’ (DND) from 1 December 2022. This takes the total number of products granted DND status over the past [...]

The post 5 products added to the Discount Not Deducted (DND) list from December 2022 appeared first on PSNC Website.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Bupropion (Zyban®) 150mg modified-release tablets. MSN/2022/100 Tier 3 – high impact Date of issue 1st December 2022 Bupropion (Zyban®) 150mg modified-release tablets will be out of stock until further notice. Various nicotine replacement therapies are available. NICE guidance highlights a range [...]

The post Medicine Supply Notification: Bupropion (Zyban® ) 150mg modified-release tablets appeared first on PSNC Website.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Acarbose 50mg and 100mg tablets. MSN/2022/099 Tier 2 – medium impact Date of issue 1st December 2022 Acarbose 50mg tablets are out of stock until w/c 5/12/2022 Acarbose 100mg tablets are out of stock until w/c 19/12/2022 Other medicines licensed for [...]

The post Medicine Supply Notification: Acarbose 50mg and 100mg tablets appeared first on PSNC Website.